Chief, Pediatric Translational Medicine ServiceMemorial Sloan Kettering Cancer CenterNew York, New York, United States
Disclosure information not submitted.
Paper 85 - BREAKING HLA RESTRICTION TO THERAPEUTICALLY TARGET A FUSION-DERIVED PUBLIC NEOANTIGEN IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Saturday, November 16, 202410:30 AM – 12:00 PM PST